|
|
||||||||
1 University of Pittsburgh, Department of Medicine, Division of Infectious Diseases, Pittsburgh, Pennsylvania 15261, USA
2 National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
Reprint requests to: Nicolas Sluis-Cremer, University of Pittsburgh, Department of Medicine, Division of Infectious Diseases, Scaife Hall S808, 3550 Terrace Street, Pittsburgh, PA 15261, USA; e-mail: CremerN{at}msx.dept-med.pitt.edu; fax: (412) 648-8521; or Michael A. Parniak, University of Pittsburgh, Department of Medicine, Division of Infectious Diseases, Scaife Hall S818, 3550 Terrace Street, Pittsburgh, PA 15261, USA; e-mail: ParniakM{at}msx.dept-med.pitt.edu; fax: (412) 648-9653.
(RECEIVED April 8, 2003; FINAL REVISION May 21, 2003; ACCEPTED May 24, 2003)
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.03130503.
| Abstract |
|---|
|
|
|---|
Keywords: HIV-1; reverse transcriptase; radiation inactivation; dimer; monomer
| Introduction |
|---|
|
|
|---|
The development of prokaryotic expression vectors encoding the amino acid sequences for RT p66 and p51 has enabled the preparation of large quantities of the p66/p51 form of RT, as well as the pure p51 and p66 polypeptides (Le Grice et al. 1995; Fletcher et al. 1996). The isolated p66 polypeptides dimerize to form p66/p66 RT homodimers (Restle et al. 1990). Furthermore, p66/p66 HIV-1 RT exhibits levels of DNA polymerase and RNase H activities similar to those of the p66/p51 RT heterodimer (Fletcher et al. 1996). However, differences in the affinity of the inter-subunit interactions between the p66/p51 and p66/p66 RT enzymes have been noted (Divita et al. 1995; Sluis-Cremer et al. 2000). The dissociation constant (Kd) for the p66/p51 RT heterodimer has been calculated to be 150 nM, whereas the Kd for the p66/p66 RT homodimer is only 2.7 µM (Divita et al. 1995; Sluis-Cremer et al. 2000). In contrast to the RT p66 polypeptide, the p51 subunit exhibits a low propensity to self-dimerizethe Kd for p51/p51 RT homodimer formation has been estimated to be 670 µM (Restle et al. 1990). Despite this inability to form stable dimers, a significant level of DNA polymerase activity has been associated with the purified RT p51 subunit (Bavand et al. 1993; Fletcher et al. 1996; Dufour et al. 1998). This latter observation is particularly surprising when one considers that the DNA polymerase activities of RT are confined exclusively to dimeric forms of the enzyme (Restle et al. 1990).
In this study, we have evaluated the importance of the inter-subunit interactions on the enzymatic functioning of the recombinant forms of HIV-1 RT by using radiation inactivation, a technique that has proven to be very useful in defining the structurefunction relationships of a large number of other proteins (Kempner 1999). Radiation target analysis is based on the direct action of ionizing radiation on macromolecules (Harmon et al. 1985), which can be achieved by irradiation at very low temperatures. Under these conditions, radiation energy from a single electron impact anywhere in a polypeptide chain is transmitted throughout the polypeptide, cleaving the polymer backbone and destroying all function. Based on the fact that the probability of a single electron impact on a protein molecule is directly proportional to the mass of the polypeptide, this technique can be used to determine the target size of both the structure of the polypeptide and the enzymatic activity associated with it (Saccomani et al. 1981). The radiation-sensitive mass of a variety of enzymes has been determined by radiation inactivation (Kempner 1988). Our results show some unexpected and interesting relationships between the subunits of HIV-1 RT and the effects that the nucleic acid template/primer (T/P) substrate has on them.
| Results |
|---|
|
|
|---|
|
|
|
104 to 132 kD, depending on the nature of the enzymatic assay (Table 1
Target analyses of HIV-1 RT in the presence of T/P
To evaluate the effect of the DNA T/P substrate on the quaternary structure of the p66/p51 and p51 recombinant forms RT, radiation inactivation experiments were carried out in which the RT (p66/p51 or p51 alone) was incubated with the homopolymeric T/P poly(dC)-oligo(dG). Two forms of poly(dC)-oligo(dG) were used that differed in molecular mass: a "large" form in which the length of the poly(dC) template was
370 nucleotides (1.2 x 105 D) and a "small" form in which the length of the poly(dC) template was 30 nucleotides (9.2 x 103 D). In both instances, an 18-nucleotide poly(dG) primer (6.3 x 103 D) was annealed to the template.
Analysis of the calculated target sizes for enzymatic activity and polypeptide structure indicates that the presence of the T/P does not significantly impact on the radiation inactivation profile of p66/p51 HIV-1 RT (Table 1
). However, significant differences in the radiation inactivation profiles of RT p51 in the presence of T/P, assessed by both DDDP activity and SDS-PAGE analyses, were noted (Fig. 3A,B). For the radiation inactivation profiles evaluated by SDS-PAGE (Fig. 3A
), the p51 subunit complexed with T/P was inactivated with an apparent molecular mass of 95 to 108 kD. This result indicates that the T/P substrates induce the formation of a p51/p51 RT homodimer in which radiation energy deposited in one of the subunits destroys both subunits. Interestingly, the size of the template in the poly(dC)-oligo(dG) had no impact on the RT p51 radiation inactivation profile: The structural target sizes calculated for RT p51 complexed with either the large or small form of poly(dC)-oligo(dG) yielded similar results (Table 1
). The inactivation profile of RT p51-T/P complex monitored by DDDP activity yielded a biphasic inactivation profile (Fig. 3B
) that could be best fit by the sum of two exponential decays. Evaluation of this more complex inactivation profile indicated that 15% of the DDDP activity was due to a structure of
42 kD, whereas 85% was associated with a 184-kD structure.
|
| Discussion |
|---|
|
|
|---|
For the p66/p51 and p66/p66 forms of HIV-1 RT, both the structural target sizes for the individual subunits (as determined from the stain intensity of the monomer band on SDSgel electrophoresis) and the functional target sizes (obtained from the residual RDDP, DDDP, and RNase H activities) correspond to the molecular masses of the dimeric proteins (i.e., 110 to 130 kD). From these data, it must be concluded that a primary ionization in either the p66 or p51 subunit destroys both subunits, resulting in the concomitant loss of enzymatic activity. That these dimeric forms of HIV-1 RT inactivate functionally as dimers is not surprising when one considers that the enzymatic activities of RT are tightly coupled to the quaternary structure of the enzyme (Restle et al. 1990, 1992). In contrast, our observation that the individual subunits in the dimer inactivated with molecular masses corresponding to the dimeric form of the enzyme was unexpected. The phenomenon of radiation energy transfer along a single polypeptide chain is most typically seen (Kempner 1999). However, the phenomenon of radiation energy transfer across noncovalent interactions is not frequently observed in multimeric proteins, and the mechanism by which this process occurs remains unclear (Kempner 1999). Previous studies using the avidinbiotin system gave no evidence for radiation damage appearing across the strong noncovalent interactions (Kempner and Miller 1990). Accordingly, other properties of the inter-subunit interaction such as size, shape, and complementarity might be considered. The extensive interactions and high affinity between the two subunits of p66/p51 may be related to the mechanism(s) of this radiation damage.
In contrast to the p66/p51 and p66/p66 forms of HIV-1 RT, the individually isolated p51 subunit is inactivated as a monomeric protein for both structure and function. This observation is consistent with data indicating that this subunit does not readily dimerize (Restle et al. 1990; Becerra et al. 1991). In this regard, the concentration of protein used in our study (
40 µM) is much less than the Kd estimated for p51/p51 homodimer formation (670 µM). Even though p51 polypeptides have a low affinity for one another, significant DNA polymerase activity has been associated with the isolated subunit, even in assays in which the effective concentration of the subunit ranges from 20 to 200 nM (Bavand et al. 1993; Fletcher et al. 1996; Dufour et al. 1998). This would indicate that either the p51 subunit is functionally active as a monomer, or the homodimeric form of the enzyme is induced by the presence of the T/P substrate.
Radiation inactivation analyses of HIV-1 RT-T/P complexes
To address the possibility that the T/P substrate induced homodimer formation in the p51 RT subunits, we carried out radiation inactivation experiments in which both the p66/p51 and p51 forms of RT were complexed with the homopolymeric substrate poly(dC)-oligo(dG). For p66/p51 RT, the presence of T/P had no effect on the radiation inactivation profiles and calculated target sizes evaluated by either RT activity or SDS-PAGE. Furthermore, preliminary experiments have indicated that the T/P was inactivated independently of RT and yielded a target size consistent with its molecular mass. In contrast to p66/p51 RT, the p51 subunit appeared to be inactivated structurally as a homodimer in the presence of the T/P, thereby indicating that the nucleic acid substrate provided a scaffold or template for RT p51/p51 homodimer formation. As described in the Introduction, the p51 subunit in the p66/p51 RT heterodimer adopts a closed conformation that is enzymatically inert and unable to accommodate T/P binding. Therefore, one must assume that the p51 must undergo significant structural rearrangements to bind T/P and to form a p51/p51 homodimeric protein. Molecular modeling studies have indicated that the monomeric form of the p51 subunit would maintain the same thermodynamically favored "closed" conformation that is observed for the subunit in the p66/p51 RT heterodimer (Wang et al. 1994). In light of this prediction, it may be possible that the T/P substrate induces an "open" conformation in the p51 subunit that then permits it to form a stable homodimer.
As opposed to the radiation inactivation profile determined by SDS-PAGE, the inactivation profile for the RT p51-T/P complex evaluated by DNA polymerase activity was more complex (Fig. 3B
). Complex inactivation curves (such as that seen in Fig. 3B
) have been ascribed to the presence of active structures of different masses (Kempner 1995). In this regard, each species is independently inactivated, resulting in an inactivation profile that is the sum of exponentials. Resolution of the components introduces considerable error in the radiation target sizes, especially in the larger ones. In the present case, it is estimated that 15% of the DDDP activity in these samples is due to a structure similar in size to the p51 subunit. The bulk of the activity (
85%) is due to a much larger structure equivalent to two or more p51 subunits. A simple explanation for these results is that 15% of the p51 subunits in these samples were not complexed to T/P.
Conclusions
In this work, we have shown by radiation inactivation analyses that the nucleic acid T/P substrate provides a scaffold or template that allows the monomeric p51 subunit of HIV-1 RT to form homodimeric forms of the enzyme. Although such forms of the enzyme might not be present during the HIV-1 viral life-cycle, our results highlight the fact that significant conformational changes in the RT subunits can be induced by cofactors such as nucleic acids. Furthermore, we have established that radiation inactivation analyses provide a useful technique for evaluating quaternary structural changes in RT, and therefore, it can readily be applied to other DNA polymerase enzymes (such as the MLV RT) for which the functional form of the enzyme has not yet been established.
| Materials and methods |
|---|
|
|
|---|
The recombinant forms of HIV-1 RT were expressed and purified as described previously (Fletcher et al. 1996). Samples for irradiation were then diluted to 2 mg/mL in 20 mM Tris-HCl (pH 7.9, 20°C) and 100 mM NaCl. This concentration of protein has previously been shown to be high enough to yield meaningful radiation target sizes and avert the need for free radical scavengers (Eichler et al. 1987; Kempner and Miller 1994). Aliquots of 0.25 mL were placed in 2-mL glass ampoules and frozen rapidly on dry ice. Samples were held at -80°C except during irradiation, which was carried out at -135°C. Radiation exposures of 0 to 100 Mrads were obtained from 10-MeV electrons produced by a linear electron accelerator (Armed Forces Radiobiology Research Institute) as described (Harmon et al. 1985). After irradiation, samples were stored at -80°C until required for analysis, at which time they were rapidly thawed and aliquots were removed for assay. The remaining material was then refrozen in aliquots on dry ice and stored at -80°C for further use. These samples were subjected to only a single additional thaw cycle before being discarded.
HIV-1 RT RDDP and DDDP activities were determined by using a fixed time assay. Reaction mixtures (50 µL total volume) contained 50 mM Tris-HCl (pH 7.8, 37°C), 60 mM KCl, 10 mM MgCl2, and 5 µg/mL of either poly(rA)-oligo(dT)12-18 (for RDDP activity) or poly(dC)-oligo(dG)12-18 (for DDDP activity), and either 20 µM [3H]TTP or 10 µM [3H]dGTP. Reactions were initiated by the addition of 50 to 80 ng of RT (9 to 12 nM final concentration). Reaction mixtures were incubated for 20 min at 37°C and then quenched with 250 µL of ice-cold 10% trichloroacetic acid (TCA) containing 20 mM sodium pyrophosphate. Quenched samples were left on ice for 20 min, then filtered by using 1.2-µm glass fiber type C filter multiwell plates (Millipore), and washed sequentially with 10% TCA containing 20 mM sodium pyrophosphate and 100% ethanol. The extent of radionucleotide incorporation was determined by liquid scintillation spectrometry.
RT RNase H activity was assayed as described previously (Starnes and Cheng 1989). Briefly, reaction mixtures (50 µL total volume) contained 50 mM Tris-HCl (pH 8.0, 37°C), 60 mM KCl, 10 mM MgCl2, and 2 µg/mL of poly([3H]rG)-poly(dC). Generally, 50 ng of RT were used. Reactions were carried out for 20 min at 37°C and then quenched by placing the tubes on ice, followed by the addition of 100 µL of cold 7% perchloric acid. After 30 min on ice, the reaction mixtures were centrifuged at 12,000g for 15 min. One hundred microliters of the supernatants was carefully removed, and the radioactivity was determined by liquid scintillation analysis.
SDS-PAGE was performed according to the method of Laemmli (1970). Aliquots of the irradiated proteins were electrophoresed, and gels were stained with Coomassie blue G250 stain (Biorad). Densitometric scans of the gels permitted quantitative determinations of the amount of monomers surviving in each irradiated sample.
SEC-HPLC was performed on a Gilson HPLC system using a 7.8- x 600-mm Biosep SEC-3000 column (Phenomenex) and a mobile phase of 20 mM Tris-HCl (pH 7.9, 20°C) and 100 mM NaCl at a flow rate of 1 mL/min. The sample injection volume was 20 µL, and elution profiles were recorded simultaneously at 260 and 280 nm. The column was equilibrated by using molecular mass markers for gel filtration chromatography (Sigma) ranging in size from 12,000 to 200,000 D.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
Becerra, S.P., Kumar, A., Lewis, M.S., Widen, S.G., Abbotts, J., Karawya, E.M., Hughes, S.H., Shiloach, J., and Wilson, S.H. 1991. Proteinprotein interactions of HIV-1 reverse transcriptase: Implications of central and C-terminal regions in subunit binding. Biochemistry 30: 1170711719.[CrossRef][Medline]
Das, K., Ding, J., Hsiou, Y., Clark Jr., A.D., Moereels, H., Koymans, L., Andries, K., Pauwels, R., Janssen, P.A., Boyer, P.L., et al. 1996. Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant. J. Mol. Biol. 264: 10851100.[CrossRef][Medline]
di Marzo Veronese, F., Copeland, T.D., DeVico, A.L., Rahman, R., Oroszlan, S., Gallo, R.C., and Sarngadharan, M.G. 1986. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science 231: 12891291.
Divita, G., Rittinger, K., Restle, T., Immendorfer, U., and Goody, R.S. 1995. Conformational stability of dimeric HIV-1 and HIV-2 reverse transcriptases. Biochemistry 34: 1633716346.[CrossRef][Medline]
Dufour, E., Dirani-Diab, R.E., Boulme, F., Fournier, M., Nevinsky, G., Tarrago-Litvak, L., Litvak, S., and Andreola, M.-L. 1998. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1. Eur. J. Biochem. 251: 487495.[Medline]
Eichler, D.C., Solomonson, L.P., Barber, M.J., McCreery, M.J., and Ness, G.C. 1987. Radiation inactivation analysis of enzymes: Effect of free radical scavengers on apparent target sizes. J. Biol. Chem. 262: 94339436.
Fletcher, R.S., Holleschak, G., Nagy, E., Arion, D., Borkow, G., Gu, Z., Wainberg, M.A., and Parniak, M.A. 1996. Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptase. Protein Expr Purif. 8: 2732.
Harmon, J.T., Nielsen, T.B., and Kempner, E.S. 1985. Molecular weight determinations from radiation inactivation. Methods Enzymol. 117: 6594.[Medline]
Hsiou, Y., Ding, J., Das, K., Clark Jr., A.D., Hughes, S.H., and Arnold, E. 1996. Structure of unliganded HIV-1 reverse transcriptase at 2.7 Å resolution: Implications of conformational changes for polymerization and inhibition mechanisms. Structure 4: 853860.[Medline]
Huang, H., Chopra, R., Verdine, G.L., and Harrison, S.C. 1998. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: Implications for drug resistance. Science 282: 16691675.
Jacobo-Molina, A., Ding, J., Nanni, R.G., Clark Jr., A.D., Lu, X., Tantillo, C., Williams, R.L., Kamer, G., Ferris, A.L., Clark, P., et al. 1993. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl. Acad. Sci. 90: 63206324.
Kempner, E.S. 1988. Molecular size determination of enzymes. In Advances in enzymology, vol. 61 (ed. A. Meister), pp. 107147. Wiley Interscience, New York.
. 1994. The mathematics of radiation target analysis. Bull. Math. Biol. 57: 883898.
. 1999. Advances in radiation target analysis. Anal. Biochem. 276: 113123[CrossRef][Medline]
Kempner, E.S. and Miller, J.H. 1990. Direct effects of radiation on the avidinbiotin system. J. Biol. Chem. 265: 1577615781
. 1995. Effect of environmental conditions on radiation target analyses. Anal. Biochem. 216: 451455
Kohlsteaedt, L.A., Wang, J., Friedman, J.M., Rice, P.A., and Steitz, T.A. 1992. Crystal structure of 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256: 17831790.
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680685[CrossRef][Medline]
Le Grice, S.F., Cameron, C.E., and Benkovic, S.J. 1995. Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase. Methods Enzymol. 262: 130144.[Medline]
Ren, J., Esnouf, R., Garman, E., Somers, D., Ross, C., Kirby, I., Keeling, J., Darby, G., Jones, Y., Stuart, D., et al. 1995. High-resolution structures of HIV-1 RT from four RT-inhibitor complexes. Nat. Struct. Biol. 2: 293302.[CrossRef][Medline]
Restle, T., Müller, B., and Goody, R.S. 1990. Dimerization of human immunodeficiency virus type 1 reverse transcriptase: A target for chemotherapeutic intervention. J. Biol. Chem. 265: 89868988
. 1992. RNase H activity of HIV reverse transcriptases is confined exclusively to the dimeric forms. FEBS Lett. 300: 97100[CrossRef][Medline]
Rodgers, D.W., Gamblin, S.J., Harris, B.A., Ray, S., Culp, J.S., Hellmig, B., Woolf, D.J., Debouck, C., and Harrison, S.C. 1995. The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. 92: 12221226.
Saccomani, G., Sachs, G., Cuppoletti, J., and Jung, C.Y. 1981. Target molecular weight of gastric (H+ + K+)-ATPase functional and structural molecular size. J. Biol. Chem. 256: 77277729
Sarafianos, S.G., Das, K., Tantillo, C., Clark Jr., A.D., Ding, J., Whitcomb, J.M., Boyer, P.L., Hughes, S.H., and Arnold, E. 2001. Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J. 20: 14491461.[CrossRef][Medline]
Sluis-Cremer, N., Dmietrinko, G.I., Balzarini, J., Camarasa, M.-J., and Parniak, M.A. 2000. Human immunodeficiency virus type-1 reverse transcriptase dimer destabilization by 1-{spiro[4',3'-[2',5'-bis-O-(tert-butyldimethylsilyl)-ß-D-ribofuranosyl]]}-3-ethylthymine. Biochemistry 39: 14271433.[CrossRef][Medline]
Starnes, MC. and Cheng, Y. 1989. Human immunodeficiency virus reverse transcriptase-associated RNase H activity. J. Biol. Chem. 264: 70737077
Telesnitsky, A. and Goff, S. 1997. Reverse transcriptase and the generation of retroviral DNA in retroviruses (eds. J. Coffin et al.), pp. 121160, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Wang, J., Smerdon, S.J., Jager, J., Kohlstaedt, L.A., Rice, P.A., Friedman, J.M., and Steitz, T.A. 1994. Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer. Proc. Natl. Acad. Sci. 91: 72427246.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
N. Sluis-Cremer and E. S. Kempner Radiation Target Analyses of DNA Template/Primer Complexes Biophys. J., May 1, 2006; 90(9): L61 - L63. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Ness, L. C. Pendleton, and M. J. McCreery Target Size Analysis by Radiation Inactivation: The Use of Free Radical Scavengers Experimental Biology and Medicine, July 1, 2005; 230(7): 455 - 463. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |